Share this article
Share this article
ALPINE, Utah, April 19, 2021 /PRNewswire/ A new study using GlycoCheck, and co-authored by GlycoCheck Chief Science Offer, Dr. Hans Vink, reports new findings of research on patients with sepsis. The study, titled Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study was published in
Critical Care.
Critical Care is a high-quality, peer-reviewed, international clinical medical journal that provides a comprehensive overview of the intensive care field.
This is a non-invasive, clinical measurement image from a real GlycoCheck test of the endothelial glycocalyx. For the first time, we can now determine quantitative microvascular scores that correlate very well with accepted clinical parameters in individual sepsis patients for a wide range of clinical severities, said Dr. Vink, Co-Founder of GlycoCheck.